United Kingdom’s first myLoop user
Oisin’s Story with the YpsoPump
Oisin Campbell is 16 years old and has been living with type 1 diabetes since he was nine years old – and has been using the YpsoPump for 4 years. In June 2022 he became the first child in Northern Ireland to use our adaptive automated insulin delivery system, myLoop.
In the beginning of his diabetes therapy, Oisin injected insulin several times a day with an insulin pen before he moved on to the YpsoPump. Now a teenager, Oisin struggled to keep his blood sugar in range, especially through the night. He desperately waited for the possibility to loop and right on time for his birthday, myLoop and the CamAPS FX system was launched in the UK.
Oisin is not only the first person to use myLoop in Northern Ireland – he also was the first person to use our YpsoPump in the country back in 2017. Being on a closed loop system was something that Oisin always hoped for regarding his diabetes therapy and he is so excited to be the first person to discover what the CamAPS FX system has to offer.
Disclaimer
The product images are for illustrative purposes only.
mylife and YpsoPump are registered trademarks of Ypsomed AG in several countries.
CamAPS is a registered trademark of CamDiab Ltd.
Dexcom and Dexcom G6 are registered trademarks of Dexcom, Inc. in the United States and/or other countries.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by mylife Diabetes Care is under license.
Other trademarks are the property of their respective owners.
myLoop: The innovation described is available in selected countries and expanding to further countries soon. Expansion is contingent upon local regulatory approval.
Insulin pumps and Automated Insulin Delivery (AID) systems can greatly improve glucose management but do not eliminate the risk of diabetic ketoacidosis (DKA). Because these systems use only rapid-acting insulin, any interruption in insulin delivery (e.g. infusion set failure, pump occlusion, empty reservoir, or device malfunction) can rapidly lead to ketosis and DKA - even if glucose readings are not very high. DKA is a serious and potentially life-threatening condition.
If you feel unwell, have persistent high glucose levels or detect positive ketones, please immediately contact your diabetes team and follow their advice. Do not rely solely on the AID system to correct high glucose or clear the ketones. Always check that insulin is being delivered and use your backup insulin method (e.g. insulin injections or insulin pens), if needed.
Medical advice can only be provided by healthcare professionals. The information contained in this material is intended for general educational purposes and should not be interpreted as medical advice or used as a substitute for consultation with a qualified healthcare professional.
For safety information on mentioned products, see mylife-diabetescare.com/safety